hybrid revascularisation;
multivessel coronary disease;
left main disease;
ARTERY-DISEASE;
BYPASS;
ANGIOPLASTY;
GRAFTS;
D O I:
暂无
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
According to current guidelines surgical revascularisation is a gold standard of treatment in patients with multivessel and left main coronary disease. Hybrid revascularisation, in two stages: first minimally invasive direct coronary artery bypass grafting procedure with left internal mammary artery conduit to left anterior descending artery and second stage-percutaneus coronary intervention with drug eluting stent in non-left anterior descending vessels may be safe and effective alternative in patients with multivessel and left main coronary disease.
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USAUniv Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA
Lee, Michael S.
Jenna Nguyen
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USAUniv Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA
机构:
Univ Virginia Hlth Syst, Div Cardiovasc, Cardiac Catheterizat Labs, Charlottesville, VA 22908 USAUniv Virginia Hlth Syst, Div Cardiovasc, Cardiac Catheterizat Labs, Charlottesville, VA 22908 USA